plendil

Product dosage: 5mg
Package (num)Per pillPriceBuy
60$0.96$57.35 (0%)🛒 Add to cart
90$0.88$86.02 $79.48 (8%)🛒 Add to cart
120$0.84$114.69 $100.61 (12%)🛒 Add to cart
180$0.80$172.04 $143.87 (16%)🛒 Add to cart
270$0.77$258.05 $207.25 (20%)🛒 Add to cart
360
$0.75 Best per pill
$344.07 $268.62 (22%)🛒 Add to cart
Synonyms

Plendil is the brand name for felodipine, a calcium channel blocker medication belonging to the dihydropyridine class. It’s primarily prescribed for the management of hypertension, or high blood pressure, and certain cases of chronic stable angina. Unlike a dietary supplement, Plendil is a prescription pharmaceutical with a well-defined mechanism and extensive clinical backing. Its role in cardiovascular medicine is significant, providing vasodilation to reduce peripheral vascular resistance, thereby lowering blood pressure and decreasing cardiac workload. For patients and clinicians navigating treatment options, understanding Plendil’s profile is crucial for optimizing therapeutic outcomes.

1. Introduction: What is Plendil? Its Role in Modern Medicine

Plendil, known generically as felodipine, is a calcium channel blocker specifically used to treat hypertension and angina. It functions by selectively inhibiting the influx of calcium ions into vascular smooth muscle and cardiac muscle, though its primary effect is on the peripheral vasculature. This action results in the relaxation of arterial smooth muscle, leading to vasodilation. In modern therapeutic regimens, Plendil is valued for its efficacy in lowering blood pressure without significantly affecting cardiac conduction, making it a suitable option for many patients, including those with certain comorbid conditions. Its development marked an advancement in antihypertensive therapy, offering a once-daily dosing option that improves adherence.

2. Key Components and Bioavailability of Plendil

The active pharmaceutical ingredient in Plendil is felodipine. It is formulated as extended-release tablets to provide consistent 24-hour plasma concentrations, which is critical for maintaining stable blood pressure control. The tablets are designed with a special coating and matrix system that controls the release of felodipine, ensuring a gradual absorption. Bioavailability of felodipine is approximately 15-20% due to significant first-pass metabolism in the liver, primarily via the cytochrome P450 3A4 enzyme system. This low bioavailability is compensated for in the dosing strategy. The extended-release formulation minimizes peak-trough fluctuations, reducing the incidence of side effects like reflex tachycardia and providing smooth antihypertensive action.

3. Mechanism of Action of Plendil: Scientific Substantiation

Plendil works by blocking L-type calcium channels in vascular smooth muscle. This blockade prevents calcium from entering the cells during depolarization, a process essential for muscle contraction. Without sufficient intracellular calcium, the smooth muscle relaxes, leading to vasodilation, primarily in the arterioles. This reduces systemic vascular resistance, which is the main determinant of its blood pressure-lowering effect. The selectivity for vascular smooth muscle over cardiac muscle means it has minimal direct effect on cardiac contractility or conduction, reducing risks of negative inotropy or heart block. Think of it like relaxing the tensed walls of tiny pipes throughout the body, allowing blood to flow with less pressure, thereby easing the workload on the heart.

4. Indications for Use: What is Plendil Effective For?

Plendil for Hypertension

Plendil is a first-line agent for managing essential hypertension. It effectively lowers both systolic and diastolic blood pressure as monotherapy or in combination with other antihypertensives like ACE inhibitors or diuretics.

Plendil for Chronic Stable Angina

In angina pectoris, Plendil reduces the frequency of anginal attacks and improves exercise tolerance. It achieves this by decreasing afterload and myocardial oxygen demand through peripheral vasodilation.

5. Instructions for Use: Dosage and Course of Administration

Dosing must be individualized based on patient response and tolerability. The usual starting dose for hypertension or angina is 5 mg once daily. Dosage may be increased to 10 mg once daily after at least 2 weeks based on therapeutic response. It should be swallowed whole, not crushed or chewed, and can be taken without regard to meals, though high-fat meals can increase bioavailability.

IndicationInitial DoseMaintenance DoseAdministration Notes
Hypertension5 mg once daily2.5 - 10 mg once dailyAdjust at 2-week intervals
Angina5 mg once daily5 - 10 mg once dailySwallow whole; do not crush

The course of administration is typically long-term, as hypertension and angina are chronic conditions requiring ongoing management.

6. Contraindications and Drug Interactions with Plendil

Plendil is contraindicated in patients with known hypersensitivity to felodipine or other dihydropyridines, and in those with severe hypotension. Caution is advised in patients with heart failure or severe aortic stenosis. Common side effects include peripheral edema, headache, flushing, and dizziness. These are often dose-dependent and may diminish over time.

Significant drug interactions occur with strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, clarithromycin), which can dramatically increase felodipine levels and the risk of adverse effects. Inducers of CYP3A4 (e.g., carbamazepine, phenytoin) can reduce its efficacy. Grapefruit juice should be avoided as it inhibits CYP3A4. Use during pregnancy is generally not recommended unless the potential benefit justifies the potential risk to the fetus.

7. Clinical Studies and Evidence Base for Plendil

The efficacy of Plendil is supported by numerous clinical trials. The HOT (Hypertension Optimal Treatment) study, published in The Lancet, demonstrated the benefits of intensive blood pressure control and included calcium channel blockers like felodipine in its regimens, showing significant reductions in cardiovascular events. Another study, the STOP-Hypertension-2 trial, found no significant difference in cardiovascular mortality between patients treated with conventional therapy (diuretics, beta-blockers) and those treated with newer agents like calcium channel blockers and ACE inhibitors, establishing Plendil’s place as an effective and safe option. Long-term data confirm its sustained antihypertensive effect and good tolerability profile over years of use.

8. Comparing Plendil with Similar Products and Choosing a Quality Product

When comparing Plendil to other calcium channel blockers, its high vascular selectivity is a key differentiator from non-dihydropyridines like verapamil and diltiazem, which have more pronounced cardiac effects. Among dihydropyridines, amlodipine is a common comparator; both offer once-daily dosing, but amlodipine has a longer half-life, while felodipine’s extended-release formulation provides comparable 24-hour coverage. The choice often comes down to individual patient response, side effect profiles (e.g., incidence of peripheral edema), and cost. For a quality product, ensure it is sourced from a reputable manufacturer and dispensed as a branded or approved generic to guarantee consistent release characteristics.

9. Frequently Asked Questions (FAQ) about Plendil

Blood pressure lowering is usually seen within 2-4 hours of the first dose, with maximal effect in 2-4 weeks. It is a long-term maintenance therapy, not a short-course treatment.

Can Plendil be combined with other antihypertensive medications?

Yes, Plendil is often used in combination with other classes like ACE inhibitors, ARBs, or diuretics for synergistic blood pressure control.

What should I do if I miss a dose of Plendil?

If you miss a dose, take it as soon as you remember. If it is almost time for the next dose, skip the missed dose. Do not double the dose to catch up.

Are there any dietary restrictions while taking Plendil?

Avoid grapefruit and grapefruit juice, as they can interfere with the metabolism of Plendil, potentially leading to toxic levels.

10. Conclusion: Validity of Plendil Use in Clinical Practice

In summary, Plendil (felodipine) remains a valid and effective choice in the antihypertensive and antianginal arsenal. Its favorable pharmacokinetic profile, proven efficacy in major clinical trials, and generally well-tolerated nature support its use. The risk-benefit profile is positive for the vast majority of patients with hypertension or chronic stable angina. When prescribed appropriately, with attention to contraindications and potential interactions, Plendil is a reliable component of long-term cardiovascular risk management strategies.


I remember when we first started using felodipine more regularly in our cardiology group back in the late 90s. There was some pushback from the old guard who were staunch beta-blocker advocates. I had this one patient, a 68-year-old retired teacher named Margaret, with stubborn hypertension that wasn’t fully controlled on her ACE inhibitor. Her ankles would swell like crazy on amlodipine. We switched her to Plendil, starting at 2.5 mg – we were being cautious. Took about three weeks, but her BP finally settled into the 130s/80s range with minimal edema. She was thrilled she could still tend her garden without getting lightheaded.

The real learning curve was with the drug interactions. We had a case, a gentleman in his 50s on multiple meds for a complex history. Started him on Plendil, and a week later he’s in the clinic with pounding headache and significant hypotension. Took us a moment to connect the dots – he’d just been prescribed a course of clarithromycin for a chest infection. His CYP3A4 was completely inhibited, felodipine levels shot up. We had to hold the dose for a couple days and restart at a lower dose once the antibiotic course finished. It was a stark reminder that even with a generally safe drug, you can’t be complacent about the med list.

What’s been interesting over the years is seeing the long-term follow-up. Many of my patients have been on Plendil for a decade or more. You see the stability. One of my long-term patients, Robert, now 79, jokes that his Plendil script is older than his grandson. His BP has remained well-controlled, and he’s avoided any major cardiac events. He still checks in annually, and his only complaint ever was some mild flushing when we had to uptitrate his dose years ago. That’s the real-world evidence that’s hard to capture in a trial – consistent, durable control with a side effect profile that people can live with long-term. It’s not the flashiest drug on the block, but it’s a workhorse, and in this business, you learn to appreciate the reliable ones.